Elsevier announces expansion to their flagship clinical decision support solution, ClinicalKey AI

New functionality and partnerships make it easier for clinicians to access crucial information at the point of care and log learning credits.

NEW YORK, March 3, 2025 /PRNewswire/ -- Elsevier, a global leader in health information and data analytics, has announced further enhancements to ClinicalKey AI, the company's leading generative AI-powered clinical decision support solution. The new functionality and integrations with strategic partners aim to transform the way healthcare providers access and utilize actionable insights, enhancing patient care and efficiency directly within the clinician's workflow.

Seamless workflows are crucial for doctors as they enable them to focus more on patient care, reduce time-consuming administrative tasks, and access relevant information efficiently. To serve the needs of busy clinicians, ClinicalKey AI is launching new workflow integrations in the electronic health record (EHR) with Epic^[1] and into the health information technology (HIT) space with iPrescribe by DrFirst, along with a new mobile app available for Apple and Android users.

The new EHR integration will streamline workflows, enabling clinicians to switch between Epic's EHR and ClinicalKey AI without needing to navigate away from patient records. ClinicalKey AI can be found in Connection Hub on Epic Showroom, providing a cohesive experience for clinicians, simplifying the process for accessing essential information at the point of care. A new ClinicalKey AI mobile app will further boost access, enhancing clinicians' ability to access critical information on the go.

Dr. Barry Wendt, Chief Medical Information Officer at St. Elizabeth Healthcare, a development partner on the Epic EHR integration, said: "Clinicians are working under increasing pressure, treating multiple patients with complex cases, and simplifying access to vital information is paramount. With ClinicalKey AI's seamless integration with the Epic EHR system, clinicians can easily move between the patient's EHR and the latest evidence-based content, helping them save valuable time when they're treating patients at the point of care."

The collaboration with DrFirst, which has solutions used by more than 450,000 prescribers, adds the power of ClinicalKey AI decision support to the company's iPrescribe by DrFirst HIT platform. "Each day, prescribers make the most of every moment to take care of their patients, even while traveling between their homes, various offices, and other facilities," said Colin Banas, M.D., M.H.A., Chief Medical Officer of DrFirst. "Making this world-class, evidence-based research tool available within the iPrescribe by DrFirst app gives healthcare providers across all practice sizes and specialties instant access to AI-powered conversational searches of clinical literature—helping them make informed prescribing decisions from anywhere."

In addition to these new access-enhancing features, ClinicalKey AI will also enable clinicians to earn, track, and claim Continuing Medical Education (CME) and Maintenance of Certification (MOC) credits directly within the platform. Healthcare professionals will be able to earn CME credits through each clinical query and response interaction, seamlessly integrating learning into their daily workflow.

Furthermore, ClinicalKey AI will support auto-submission of MOC credits to American Boards of eight different specialties (internal medicine, pediatrics, anesthesiology, surgery, pathology, otolaryngology, orthopedic surgery and thoracic surgery). This will make ClinicalKey AI the first AI solution of this kind with this capability.

Omry Bigger, President of Clinical Solutions at Elsevier said: "Healthcare professionals continue to face growing pressures on their time while operating in a fast-moving work environment. Since launching ClinicalKey AI in 2024 as the first Gen-AI solution of its kind, we have continued to expand functionality to support clinicians by streamlining processes, improving access and boosting CME, helping them respond to the challenges they face every day."

ClinicalKey AI is available in over 50 countries and provides answers from a content set that is specifically curated for point of care questions. It enables access to Elsevier titles such as The Lancet, Goldman-Cecil, as well as non-Elsevier titles and a host of other evidence-based sources. Today's announcement builds on the expanded partnership with the American College of Cardiology (ACC) announced earlier this year, which made the ACC's Clinical Practice Guidelines and Expert Consensus Decision Pathways on a range of cardiology topics available on ClinicalKey AI.

You can learn more about ClinicalKey AI on our website, and also at the upcoming 2025 HIMSS Conference in Las Vegas. Join the Elsevier team at booth 3616 and AI Pavilion Kiosk 121-14 to find out more about ClinicalKey AI. You can also hear from Elsevier spokespeople Dr. Amber Featherstone-Uwague (3:10 p.m., March 4) and Dr. Paul "PJ" Helmuth (2 p.m., March 5) at speaking sessions in the AI Pavillion.

About Elsevier
As a global leader in scientific information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies.

We have supported the work of our research and healthcare communities for more than 140 years. Our 9,500 employees around the world, including 2,500 technologists, are dedicated to supporting researchers, librarians, academic leaders, funders, governments, R&D-intensive companies, doctors, nurses, future healthcare professionals and educators in their critical work. Our 2,900 scientific journals and iconic reference books include the foremost titles in their fields, including Cell Press, The Lancet and Gray's Anatomy.

Together with the Elsevier Foundation, we work in partnership with the communities we serve to advance inclusion and diversity in science, research and healthcare in developing countries and around the world. 

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information on our work, digital solutions and content, visit www.elsevier.com. 

About iPrescribe by DrFirst
iPrescribe by DrFirst is the industry-leading e-prescribing solution, trusted by healthcare providers throughout the U.S. It enables safe and efficient prescribing of controlled and non-controlled substances anytime, anywhere. Built for mobility and designed to adapt to any workflow, iPrescribe ensures seamless, compliant prescribing across all practice settings. Whether used as a standalone mobile solution or integrated with an EHR, iPrescribe delivers flexibility for in-office and after-hours needs. DrFirst solutions help 100 million patients a year and are used by more than 450,000 prescribers, 71,000 pharmacies, 270 EHRs and health information systems, and over 2,000 hospitals in the U.S. To learn more, visit iPrescribe.com and DrFirst.com.

Logo - https://mma.prnewswire.com/media/2628519/5194789/Elsevier_Logo.jpg